65 plus: A randomized phase III trial of pemetrexed and bevacizumab versus pemetrexed, bevacizumab, and carboplatin as first-line treatment for elderly patients with advanced nonsquamous, non-small cell lung cancer (NSCLC).

被引：0

作者：

Schuette, Wolfgang

Nagel, Sylke

Schneider, Claus-Peter

Engel-Riedel, Walburga

Schumann, Christian

Kohlhaeufl, Martin

Serke, Monika

Hoeffken, Gert

Kortsik, Cornelius

Reck, Martin

机构：

[1] Hosp Martha Maria Halle Doelau, Halle, Germany

[2] Cent Hosp Bad Berka, Bad Berka, Germany

[3] Merheim Lung Hosp, Cologne Clin, Cologne, Germany

[4] Univ Hosp Ulm, Ulm, Germany

[5] Hosp Schillerhoehe Gerlingen, Gerlingen, Germany

[6] Lung Clin Hemer, Hemer, Germany

[7] Specialty Hosp Coswig, Coswig, Germany

[8] Catholic Hosp Mainz, Mainz, Germany

[9] Lung Clin Grosshansdorf, Grosshansdorf, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8013

引用

页数：1